DC*MADS, 1992 (Live Births)
The Washington, DC, Metropolitan Area Drug Study (DC*MADS) was conducted
in 1991, and included special analyses of homeless and transient
delivering live births in the DC hospitals. DC*MADS was undertaken to
assess the full extent of the drug problem in one metropolitan
area. The study was comprised of 16 separate studies that focused on
different sub-groups, many of which are typically not included or are
underrepresented in household surveys.
The DC*MADS: Drug Use
Among Women Delivering Livebirths in DC Hospitals was designed to
examine the nature and extent of drug use among women delivering live
births in eight Washington, DC, hospitals participating in the
study. Data from the questionnaires include prenatal care, health
problems during pregnancy, pregnancy drug use history, needle use,
polysubstance use, patterns of use, respondent's general experiences
with drug use, including perceptions of the risks and consequences of
use, occurrence of psychological and emotional problems, income and
insurance coverage, treatment experiences, and maternal and infant
outcomes. Medical records were abstracted from the women and their
infants to document medical problems. Abstracted data on the mothers
included demographics, discharge diagnoses, disposition at discharge,
and results of urine screens. Abstracted data on infants included
delivery information, status at discharge, discharge
diagnoses/procedures, and first urine toxicology screen results.
United States Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse. Washington, DC, Metropolitan Area Drug Study (DC*MADS), 1992: Drug Use Among DC Women Delivering Live Births in DC Hospitals. Ann Arbor, MI: Inter-university Consortium for Political and Social Research [distributor], 2008-12-15. https://doi.org/10.3886/ICPSR02347.v2
Export Citation:
- RIS (generic format for RefWorks, EndNote, etc.)
- EndNote
United States Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse
Users are reminded by the United States Department of
Health and Human Services that these data are to be used solely for
statistical analysis and reporting of aggregated information and not
for the investigation of specific individuals or treatment
facilities.